Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

P Hermann, B Appleby, JP Brandel, B Caughey… - The Lancet …, 2021 - thelancet.com
Summary Sporadic Creutzfeldt-Jakob disease is a fatal neurodegenerative disease caused
by misfolded prion proteins (PrP Sc). Effective therapeutics are currently not available and …

Neurofilaments as biomarkers in neurological disorders

M Khalil, CE Teunissen, M Otto, F Piehl… - Nature Reviews …, 2018 - nature.com
Neuroaxonal damage is the pathological substrate of permanent disability in various
neurological disorders. Reliable quantification and longitudinal follow-up of such damage …

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease

O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser… - Nature medicine, 2019 - nature.com
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for
various cerebral proteopathies. Here we leverage the unique characteristics of the …

[HTML][HTML] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE …

C Darryl, E Bertini, KJ Swoboda, WL Hwu… - Neuromuscular …, 2019 - Elsevier
Spinal muscular atrophy (SMA) is a neurodegenerative disease associated with severe
muscle atrophy and weakness in the limbs and trunk. We report interim efficacy and safety …

Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder

O Hansson, S Janelidze, S Hall, N Magdalinou… - Neurology, 2017 - AAN Enterprises
Objective: To determine if blood neurofilament light chain (NfL) protein can discriminate
between Parkinson disease (PD) and atypical parkinsonian disorders (APD) with equally …

[HTML][HTML] Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and …

D Jiang, F Gong, X Ge, C Lv, C Huang, S Feng… - Journal of …, 2020 - Springer
Background Spinal cord injury (SCI) is a catastrophic injury that can cause irreversible motor
dysfunction with high disability. Exosomes participate in the transport of miRNAs and play an …

[HTML][HTML] Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases

M Bacioglu, LF Maia, O Preische, J Schelle, A Apel… - Neuron, 2016 - cell.com
A majority of current disease-modifying therapeutic approaches for age-related
neurodegenerative diseases target their characteristic proteopathic lesions (α-synuclein …

Plasma biomarkers of astrocytic and neuronal dysfunction in early-and late-onset Alzheimer's disease

FM Elahi, KB Casaletto, R La Joie, SM Walters… - Alzheimer's & …, 2019 - Elsevier
Introduction We investigated plasma proteomic markers of astrocytopathy, brain
degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset …

Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease

WW Aamodt, T Waligorska, J Shen… - Movement …, 2021 - Wiley Online Library
Background Neurofilament light chain protein (NfL) is a promising biomarker of
neurodegeneration. Objectives To determine whether plasma and CSF NfL (1) associate …

Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis

CH Lu, C Macdonald-Wallis, E Gray, N Pearce… - Neurology, 2015 - AAN Enterprises
Objective: To test blood and CSF neurofilament light chain (NfL) levels in relation to disease
progression and survival in amyotrophic lateral sclerosis (ALS). Methods: Using an …